Tatiana N. Veselova
Tatiana N. Veselova has a total of 180 co-authors. Here are the top co-authors by number of shared publications:
- Sergey K. Ternovoy
Department of Radiology, I.M. Sechenov First Moscow State Medical University (SechenovUniversity), Moscow, 119992, Russia
15 shared publications - Dmitry V. Pevzner
Chazov National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation; M.F. Vladimirsky Moscow Regional Research and Clinical Institute
12 shared publications - Tatiana S. Sukhinina
Chazov National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
11 shared publications - Irina N. Merkulova
Chazov National Medical Research Center of Cardiology
10 shared publications - Tamila V. Martynyuk
E.I. Chazov National Medical Research Center of Cardiology; N.I. Pirogov Russian National Research Medical University
10 shared publications - I. I. Staroverov
Chazov National Medical Research Center of Cardiology
9 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Intermedservice Ltd in Systemic Hypertension
- Vol. 23 (3) , 31-38
Analysis of pulmonary perfusion in patients with idiopathic pulmonary hypertension on therapy using lung subtraction CT
Relevance . It is known that patients with idiopathic pulmonary hypertension (IPH) develop characteristic patchy defects of lung tissue perfusion. According to the literature, patients with severe perfusion disorders tended to have a more severe course of the disease than patients with relatively normal lung tissue perfusion and were more often treated with pathogenetic therapy. Thus, the study of lung perfusion in patients with IPH on the background of specific therapy is of particular scientific and practical interest. Objective . To evaluate lung perfusion in patients with IPH depending on clinical, functional, and hemodynamic parameters during specific therapy using subtraction computed tomography pulmonary angiography. Materials and methods . Twenty patients with a newly diagnosed IPH, according to clinical guidelines, were enrolled in the study at the Tomography Department of the A.L. Myasnikov Institute of Cardiology and Cardiology, E.I. Chazov National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation. All patients underwent subtraction CT pulmonary angiography using an Aquilion ONE 640 VISION Edition CT scanner with 320 detector rows, using the lung subtraction protocol. Analysis of the obtained images included a visual segmental assessment of perfusion using iodine maps during the initial and repeat CT scans (after at least 6 months of stable PAH therapy). Results . A significant correlation was found between the baseline perfusion index (PI) 32.5 [19.4; 43.7]% and the initial mean pulmonary artery pressure (before specific therapy) according to right heart catheterization 61.5 [54.5; 68.7] mmHg (r=0,6, p =0,007), and transthoracic echocardiography 62.5 [53.7; 73.7] mmHg (r=0,8, p=0,001). When assessing the dynamics against the background of therapy, an improvement in lung perfusion was noted. The initial values of IP were 32.5% [19.4; 43.7], after the prescription of therapy 22.5% [14.4; 30], p=0,038. Conclusion . Subtraction CT angiopulmonography with assessment of lung perfusion can potentially be used as an additional method in assessing the severity of patients with IPH. Also, the study of the perfusion of the lung tissue in dynamics may be of interest in order to assess the results of the ongoing treatment.
- 29 October 2026
- Published by Intermedservice Ltd in Systemic Hypertension
- Vol. 23 (3) , 31-38
Open AccessAnalysis of pulmonary perfusion in patients with idiopathic pulmonary hypertension on therapy using lung subtraction CT
Relevance . It is known that patients with idiopathic pulmonary hypertension (IPH) develop characteristic patchy defects of lung tissue perfusion. According to the literature, patients with severe perfusion disorders tended to have a more severe course of the disease than patients with relatively normal lung tissue perfusion and were more often treated with pathogenetic therapy. Thus, the study of lung perfusion in patients with IPH on the background of specific therapy is of particular scientific and practical interest. Objective . To evaluate lung perfusion in patients with IPH depending on clinical, functional, and hemodynamic parameters during specific therapy using subtraction computed tomography pulmonary angiography. Materials and methods . Twenty patients with a newly diagnosed IPH, according to clinical guidelines, were enrolled in the study at the Tomography Department of the A.L. Myasnikov Institute of Cardiology and Cardiology, E.I. Chazov National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation. All patients underwent subtraction CT pulmonary angiography using an Aquilion ONE 640 VISION Edition CT scanner with 320 detector rows, using the lung subtraction protocol. Analysis of the obtained images included a visual segmental assessment of perfusion using iodine maps during the initial and repeat CT scans (after at least 6 months of stable PAH therapy). Results . A significant correlation was found between the baseline perfusion index (PI) 32.5 [19.4; 43.7]% and the initial mean pulmonary artery pressure (before specific therapy) according to right heart catheterization 61.5 [54.5; 68.7] mmHg (r=0,6, p =0,007), and transthoracic echocardiography 62.5 [53.7; 73.7] mmHg (r=0,8, p=0,001). When assessing the dynamics against the background of therapy, an improvement in lung perfusion was noted. The initial values of IP were 32.5% [19.4; 43.7], after the prescription of therapy 22.5% [14.4; 30], p=0,038. Conclusion . Subtraction CT angiopulmonography with assessment of lung perfusion can potentially be used as an additional method in assessing the severity of patients with IPH. Also, the study of the perfusion of the lung tissue in dynamics may be of interest in order to assess the results of the ongoing treatment.
- Open Access
- 13 August 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (6) , 6923
Post-infarction ventricular septal rupture: short-term outcomes. Seven-year Russian single-center experience
Aim . To evaluate short-term clinical and procedural outcomes in patients with post-infarction ventricular septal rupture (PIVSR). Material and methods . This single-center, retrospective, non-randomized, observational cohort study included patients with PIVSR admitted to the Chazov National Medical Research Center of Cardiology in Moscow between 2019 and 2025. The analysis was conducted according to the type of procedure performed. The primary endpoint was any-cause inhospital mortality, with secondary endpoints including inhospital cardiovascular mortality and the rate of technical and procedural success after curative treatment. Results . In the period 2019-2025, the study included 94 patients with PIVSR (mean age, 68,5±12 years women, 56,4%). Open surgical repair was performed in 35,1% (33/94) of patients, while percutaneous closure (PC) — in 50,0% (47/94), conservative treatment — in 12,8% (12/94), and heart transplantation or implantation of a long-term left ventricular assist device with immediate open surgical repair. Secondary open surgical repair after PC was performed in 14,9% (7/47) of patients. Cardiogenic shock occurred in 62,8% (59/94) of patients: in the open surgical repair group — in 36,4% (12/33), in the PC group — in 83% (39/47). Mechanical circulatory support was used in 53,2% (50/94) of cases. Any-cause inhospital mortality was 53,3% (49/92): 74,5% (35/47) with PC, and 21,2% (7/33) with open surgical repair, and 58,3% (7/12) with conservative treatment. In the general group, 34,8% (32/92) of patients died from cardiovascular causes. In the open surgical repair and PC groups, technical success was achieved in 97,5% and 87,2%, and procedural success — in 72,7% and 51,1%, respectively. Conclusion . Approximately half of patients with PIVSR survive to discharge with a comprehensive treatment approach. In our center’s experience, various curative treatment methods complement each other and are used in patient populations with different clinical severity. The results highlight the need for further research aimed at optimizing the strategy, specifically the choice of intervention type and timing, and the use of mechanical circulatory support.
- 13 August 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (6) , 6923
Open AccessPost-infarction ventricular septal rupture: short-term outcomes. Seven-year Russian single-center experience
Aim . To evaluate short-term clinical and procedural outcomes in patients with post-infarction ventricular septal rupture (PIVSR). Material and methods . This single-center, retrospective, non-randomized, observational cohort study included patients with PIVSR admitted to the Chazov National Medical Research Center of Cardiology in Moscow between 2019 and 2025. The analysis was conducted according to the type of procedure performed. The primary endpoint was any-cause inhospital mortality, with secondary endpoints including inhospital cardiovascular mortality and the rate of technical and procedural success after curative treatment. Results . In the period 2019-2025, the study included 94 patients with PIVSR (mean age, 68,5±12 years women, 56,4%). Open surgical repair was performed in 35,1% (33/94) of patients, while percutaneous closure (PC) — in 50,0% (47/94), conservative treatment — in 12,8% (12/94), and heart transplantation or implantation of a long-term left ventricular assist device with immediate open surgical repair. Secondary open surgical repair after PC was performed in 14,9% (7/47) of patients. Cardiogenic shock occurred in 62,8% (59/94) of patients: in the open surgical repair group — in 36,4% (12/33), in the PC group — in 83% (39/47). Mechanical circulatory support was used in 53,2% (50/94) of cases. Any-cause inhospital mortality was 53,3% (49/92): 74,5% (35/47) with PC, and 21,2% (7/33) with open surgical repair, and 58,3% (7/12) with conservative treatment. In the general group, 34,8% (32/92) of patients died from cardiovascular causes. In the open surgical repair and PC groups, technical success was achieved in 97,5% and 87,2%, and procedural success — in 72,7% and 51,1%, respectively. Conclusion . Approximately half of patients with PIVSR survive to discharge with a comprehensive treatment approach. In our center’s experience, various curative treatment methods complement each other and are used in patient populations with different clinical severity. The results highlight the need for further research aimed at optimizing the strategy, specifically the choice of intervention type and timing, and the use of mechanical circulatory support.
- Open Access
- 7 July 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (5) , 6883
Patient profile and clinical features of postinfarction ventricular septal rupture. Seven-year experience at a single center in Russia
Aim . To study the clinical and demographic data of a non-selective population of patients with post-infarction ventricular septal rupture (VSR) at a single center in Russia. Material and methods . This single-center, retrospective, observational cohort study included all patients with post-infarction VSR admitted to the Chazov National Medical Research Center of Cardiology in Moscow between 2019 and 2025. Demographics, comorbidities, clinical course, echocardiographic data, frequency and timing of open surgical repair and percutaneous closure, mechanical circulatory support, and patient routing were assessed using descriptive statistics. A search for independent factors influencing the choice of primary intervention was conducted using multiple logistic regression. Results . A total of 94 patients with post-infarction VSR were included in the study between 2019 and 2025. The mean age was 68,5±12 years (women, 56,4%). The most common medical history included hypertension (82/94, 87,2%), diabetes (35/94, 37,2%) and obesity (27/94, 28,7%). An attempt of coronary reperfusion was made in 69,2% of patients (65/94), while only in 28,7% (27/94) it was timely and successful. Cardiogenic shock (CS) occurred in 66% (62/94) of cases, most often stages D 24/62 (38,7%) and E 20/62 (32,3%). Mechanical circulatory support was used in 53,2% of cases. Any curative treatment was performed in 87,2% of cases. Independent predictors of percutaneous closure were pre-intervention CS (8,31 [2,77-24,93], pConclusion . Patients with post-infarction VSR have significant comorbidity. Timely successful coronary reperfusion was achieved in less than a third of patients. A high incidence of end-stage CS is noted, which, along with age over 65,5 years, is an independent predictor of performing percutaneous closure.
- 7 July 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (5) , 6883
Open AccessPatient profile and clinical features of postinfarction ventricular septal rupture. Seven-year experience at a single center in Russia
Aim . To study the clinical and demographic data of a non-selective population of patients with post-infarction ventricular septal rupture (VSR) at a single center in Russia. Material and methods . This single-center, retrospective, observational cohort study included all patients with post-infarction VSR admitted to the Chazov National Medical Research Center of Cardiology in Moscow between 2019 and 2025. Demographics, comorbidities, clinical course, echocardiographic data, frequency and timing of open surgical repair and percutaneous closure, mechanical circulatory support, and patient routing were assessed using descriptive statistics. A search for independent factors influencing the choice of primary intervention was conducted using multiple logistic regression. Results . A total of 94 patients with post-infarction VSR were included in the study between 2019 and 2025. The mean age was 68,5±12 years (women, 56,4%). The most common medical history included hypertension (82/94, 87,2%), diabetes (35/94, 37,2%) and obesity (27/94, 28,7%). An attempt of coronary reperfusion was made in 69,2% of patients (65/94), while only in 28,7% (27/94) it was timely and successful. Cardiogenic shock (CS) occurred in 66% (62/94) of cases, most often stages D 24/62 (38,7%) and E 20/62 (32,3%). Mechanical circulatory support was used in 53,2% of cases. Any curative treatment was performed in 87,2% of cases. Independent predictors of percutaneous closure were pre-intervention CS (8,31 [2,77-24,93], pConclusion . Patients with post-infarction VSR have significant comorbidity. Timely successful coronary reperfusion was achieved in less than a third of patients. A high incidence of end-stage CS is noted, which, along with age over 65,5 years, is an independent predictor of performing percutaneous closure.
- Open Access
- 2 May 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (4) , 202-208
A "risk score scale" based on computed tomography angiography of the coronary arteries to assess the risk of cardiovascular events in the first year after acute coronary syndrome
Aim. Development of a “Risk Score Scale” (RSS) to assess the risk of Major Adverse Cardiovascular Events (MACE) based on computed tomographic angiography (CTА) of the coronary arteries in patients with acute coronary syndrome. Materials and methods. The study included 249 pаtients with acute coronary syndrome (77.5% of men, age 58.2±10.7 years). Myocardial infarction occurred in 73.5% of patients, unstable angina – in 26.5%. After percutaneous coronary intervention CTA was performed by 320 – row CT scanner. 30 CTА characteristics were determined. Results. During 39.1 [18.0; 57.4] months of follow-up, 28.5% patients had combined primary endpoint events (PEE) including nonfatal myocardial infarction, unstable angina, cardiac death, unplanned percutaneous coronary intervention, ischemic stroke. RSS was developed by ROC analysis of the significant CT predictors of PEE, which were determined using a univariate Cox model. The uncensored period was 305 days – 26 PEE. Using the Yuden method, cut-off values, AUC values, and other indicators were calculated for predictors. RSS included the following 8 most optimal predictors with their cut-off values and score values: “number of coronary arteries with plaques” 1.5 – 1.0 point; “maximum plaque length” 14.5 mm – 1.16 points; “total length of plaques” 22.5 mm – 1.17; “maximal coronary stenosis” 77.5% – 1.23; “number of plaques with ≥50% stenosis” 3,5 – 1.1; “minimum plaque density” 29.1 HU – 1.33; “number of plaques with spotty calcifications” 1.5 – 1.23; “number of low attenuation plaque 30 HU” 0.5 – 1.00. For the resulting RSS calculated threshold value was 3 points. A score of 3 points indicates a high risk of MACE: odds ratio 7.2, 95% CI 2.6–19.7 (p0.0001). Conclusion. The use of RSS is a new and practically significant technique that makes it possible to improve the risk stratification of adverse outcomes.
- 2 May 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (4) , 202-208
Open AccessA "risk score scale" based on computed tomography angiography of the coronary arteries to assess the risk of cardiovascular events in the first year after acute coronary syndrome
Aim. Development of a “Risk Score Scale” (RSS) to assess the risk of Major Adverse Cardiovascular Events (MACE) based on computed tomographic angiography (CTА) of the coronary arteries in patients with acute coronary syndrome. Materials and methods. The study included 249 pаtients with acute coronary syndrome (77.5% of men, age 58.2±10.7 years). Myocardial infarction occurred in 73.5% of patients, unstable angina – in 26.5%. After percutaneous coronary intervention CTA was performed by 320 – row CT scanner. 30 CTА characteristics were determined. Results. During 39.1 [18.0; 57.4] months of follow-up, 28.5% patients had combined primary endpoint events (PEE) including nonfatal myocardial infarction, unstable angina, cardiac death, unplanned percutaneous coronary intervention, ischemic stroke. RSS was developed by ROC analysis of the significant CT predictors of PEE, which were determined using a univariate Cox model. The uncensored period was 305 days – 26 PEE. Using the Yuden method, cut-off values, AUC values, and other indicators were calculated for predictors. RSS included the following 8 most optimal predictors with their cut-off values and score values: “number of coronary arteries with plaques” 1.5 – 1.0 point; “maximum plaque length” 14.5 mm – 1.16 points; “total length of plaques” 22.5 mm – 1.17; “maximal coronary stenosis” 77.5% – 1.23; “number of plaques with ≥50% stenosis” 3,5 – 1.1; “minimum plaque density” 29.1 HU – 1.33; “number of plaques with spotty calcifications” 1.5 – 1.23; “number of low attenuation plaque 30 HU” 0.5 – 1.00. For the resulting RSS calculated threshold value was 3 points. A score of 3 points indicates a high risk of MACE: odds ratio 7.2, 95% CI 2.6–19.7 (p0.0001). Conclusion. The use of RSS is a new and practically significant technique that makes it possible to improve the risk stratification of adverse outcomes.
- 26 January 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (2S)
Chronic thromboembolic pulmonary disease: status artium (literature review)
The concept of chronic thromboembolic pulmonary disease (CTEPD) describes patients with persistent pulmonary thrombosis and symptoms but without pulmonary hypertension (PH) at rest. In the international literature, CTEPD is an all-encompassing term encompassing all symptomatic patients with post-thromboembolic pulmonary artery lesions as demonstrated by computed tomography pulmonary angiography and/or perfusion defects on pulmonary ventilation-perfusion scintigraphy without ventilation defects, regardless of PH at rest. Russian experts have retained the historical term chronic thromboembolic pulmonary hypertension (CTEPH) for patients with PH at rest. In this review, we will examine key aspects of the diagnosis and treatment of patients with CTEPD without PH.
- 26 January 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (2S)
Chronic thromboembolic pulmonary disease: status artium (literature review)
The concept of chronic thromboembolic pulmonary disease (CTEPD) describes patients with persistent pulmonary thrombosis and symptoms but without pulmonary hypertension (PH) at rest. In the international literature, CTEPD is an all-encompassing term encompassing all symptomatic patients with post-thromboembolic pulmonary artery lesions as demonstrated by computed tomography pulmonary angiography and/or perfusion defects on pulmonary ventilation-perfusion scintigraphy without ventilation defects, regardless of PH at rest. Russian experts have retained the historical term chronic thromboembolic pulmonary hypertension (CTEPH) for patients with PH at rest. In this review, we will examine key aspects of the diagnosis and treatment of patients with CTEPD without PH.
- Open Access
- 29 October 2025
- Published by Intermedservice Ltd in Systemic Hypertension
- Vol. 22 (3) , 19-24
Features of diagnostic search and choice of treatment strategy in patients with chronic thromboembolic pulmonary hypertension associated with systemic lupus erythematosus and antiphospholipid syndrome: case report
Chronic thromboembolic pulmonary hypertension (CTEPH) is a life-threatening form of pulmonary hypertension, caused by obstruction of the large and/or medium pulmonary arteries by organized thrombi. Currently, a multimodal approach, including surgical and endovascular treatment, using modern specific drugs has improved treatment results. This clinical case demonstrates the successful treatment with triple PAH-specific therapy and balloon angioplasty of the pulmonary arteries in the patient with severe CTEPH associated with systemic lupus erythematosus and antiphospholipid syndrome.
- 29 October 2025
- Published by Intermedservice Ltd in Systemic Hypertension
- Vol. 22 (3) , 19-24
Open AccessFeatures of diagnostic search and choice of treatment strategy in patients with chronic thromboembolic pulmonary hypertension associated with systemic lupus erythematosus and antiphospholipid syndrome: case report
Chronic thromboembolic pulmonary hypertension (CTEPH) is a life-threatening form of pulmonary hypertension, caused by obstruction of the large and/or medium pulmonary arteries by organized thrombi. Currently, a multimodal approach, including surgical and endovascular treatment, using modern specific drugs has improved treatment results. This clinical case demonstrates the successful treatment with triple PAH-specific therapy and balloon angioplasty of the pulmonary arteries in the patient with severe CTEPH associated with systemic lupus erythematosus and antiphospholipid syndrome.
- 18 September 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (3)
Factors determining the effectiveness of various antithrombotic therapy regimens after coronary artery bypass surgery in patients with diffuse lesions and small diameter of coronary arteries: a 12-month prospective follow-up
Objective. To evaluate the factors determining prognosis within a year after coronary artery bypass grafting (CABG) in patients with diffuse lesions and/or small (<1.5mm) diameter of target arteries, as well as the effect of antithrombotic therapy (ATT) on clinical outcomes and graft occlusion. Material and methods. A single-center open prospective study included patients who underwent CABG with diffuse lesions and/or small (<1.5 mm) diameter of at least one coronary artery. This study was intended to compare different ATT regimens. Depending on therapy, patients were divided into 3 groups: ASA, ASA+C, ASA+R. Clinical outcomes were thrombotic complications in any vascular bed, recurrent angina and/or need for repeat percutaneous coronary intervention, major bleeding (BARC 2—5). Loss of bypass grafts was assessed according to CT angiography. Results. The final analysis included 201 patients. The median prospective follow-up was 12 months. There was 1 thrombotic complication (non-fatal myocardial infarction) and 3 cases of bleeding. None event led to fatal outcomes. Compared with ASA alone, any variant of multicomponent ATT was associated with lower incidence of angina recurrence and/or need for PCI (37.3 vs. 20.3%, p=0.010). The highest effects of multicomponent therapy were observed in patients without «target» LDL-C values. The incidence of angina recurrence and/or need for PCI in the ASA and ASA+C groups was 41.1 vs. 12.1% (OR=0.291), respectively, incidence of occlusion of at least one graft — 68.4% and 39.3% (OR=0.657). The incidence of occlusions of small-diameter venous grafts was significantly higher in the aspirin group compared to any variant of enhanced therapy (53.5 vs. 22.5%, p=0.0007). Conclusion. «Enhanced» ATT significantly reduces the risks of recurrent angina and/or the need for PCI, as well as the incidence of graft occlusion in patients without «target» LDL-C. «Enhanced» therapy has a protective effect on venous grafts to small (<1.5 mm) arteries.
- 18 September 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (3)
Factors determining the effectiveness of various antithrombotic therapy regimens after coronary artery bypass surgery in patients with diffuse lesions and small diameter of coronary arteries: a 12-month prospective follow-up
Objective. To evaluate the factors determining prognosis within a year after coronary artery bypass grafting (CABG) in patients with diffuse lesions and/or small (<1.5mm) diameter of target arteries, as well as the effect of antithrombotic therapy (ATT) on clinical outcomes and graft occlusion. Material and methods. A single-center open prospective study included patients who underwent CABG with diffuse lesions and/or small (<1.5 mm) diameter of at least one coronary artery. This study was intended to compare different ATT regimens. Depending on therapy, patients were divided into 3 groups: ASA, ASA+C, ASA+R. Clinical outcomes were thrombotic complications in any vascular bed, recurrent angina and/or need for repeat percutaneous coronary intervention, major bleeding (BARC 2—5). Loss of bypass grafts was assessed according to CT angiography. Results. The final analysis included 201 patients. The median prospective follow-up was 12 months. There was 1 thrombotic complication (non-fatal myocardial infarction) and 3 cases of bleeding. None event led to fatal outcomes. Compared with ASA alone, any variant of multicomponent ATT was associated with lower incidence of angina recurrence and/or need for PCI (37.3 vs. 20.3%, p=0.010). The highest effects of multicomponent therapy were observed in patients without «target» LDL-C values. The incidence of angina recurrence and/or need for PCI in the ASA and ASA+C groups was 41.1 vs. 12.1% (OR=0.291), respectively, incidence of occlusion of at least one graft — 68.4% and 39.3% (OR=0.657). The incidence of occlusions of small-diameter venous grafts was significantly higher in the aspirin group compared to any variant of enhanced therapy (53.5 vs. 22.5%, p=0.0007). Conclusion. «Enhanced» ATT significantly reduces the risks of recurrent angina and/or the need for PCI, as well as the incidence of graft occlusion in patients without «target» LDL-C. «Enhanced» therapy has a protective effect on venous grafts to small (<1.5 mm) arteries.
- Open Access
- 15 July 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (5) , 4347
Efficacy and safety of antiplatelet therapy intensification with clopidogrel after coronary artery bypass grafting in patients with diffuse coronary artery disease: preliminary results of a one-year study
Aim. To study the clinical outcomes and the frequency of bypass graft occlusions in patients with diffuse coronary artery disease (CAD) and small (Material and methods. This prospective randomized study included 94 patients with a stable diffuse multivessel CAD with a small (Results. There were a total of 349 bypasses with a total occlusion rate of 54 (16%). The bypass occlusion rate in the ASA and ASA+clopidogrel groups was very close as follows: 19 vs 13% (p=0,191). In the subanalysis of the bypass graft function related to arteries with a diameter Conclusion. Bypass graft occlusions related to arteries of small (<1,5 mm) diameter, assessed one year after CABG, develop significantly less often with ASA+clopidogrel combination therapy.
- 15 July 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (5) , 4347
Open AccessEfficacy and safety of antiplatelet therapy intensification with clopidogrel after coronary artery bypass grafting in patients with diffuse coronary artery disease: preliminary results of a one-year study
Aim. To study the clinical outcomes and the frequency of bypass graft occlusions in patients with diffuse coronary artery disease (CAD) and small (Material and methods. This prospective randomized study included 94 patients with a stable diffuse multivessel CAD with a small (Results. There were a total of 349 bypasses with a total occlusion rate of 54 (16%). The bypass occlusion rate in the ASA and ASA+clopidogrel groups was very close as follows: 19 vs 13% (p=0,191). In the subanalysis of the bypass graft function related to arteries with a diameter Conclusion. Bypass graft occlusions related to arteries of small (<1,5 mm) diameter, assessed one year after CABG, develop significantly less often with ASA+clopidogrel combination therapy.
- Open Access
- 15 April 2025
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 97 (3) , 279-288
Expert consensus on approaches to risk stratification and choice of therapy in patients with inoperable and residual chronic thromboembolic pulmonary hypertension
On December 13, 2024, the final working group meeting was held, the purpose of which was to discuss the common position of experts on the problem of chronic thromboembolic pulmonary hypertension of various specialties: cardiologists, cardiac surgeons, pulmonologists, on issues of assessing the operability of patients, risk stratification and choice of therapy in patients with inoperable and residual forms of pathology. The discussion field included a wide range of issues that often arise in real clinical practice, but specific answers to them are not given in national and foreign guidelines. On November 8, 2024, at the preparatory stage, 16 experts under the leadership of Academician of the Russian Academy of Sciences I.E. Chazova (chairman) formulated questions for the preparation of a consensus document (without discussion), consistently discussing the feasibility of including each issue in the document and distributing tasks for the final session. Then, at the intermediate stage, experts searched and systematized scientific information on the formulated questions in the PubMed and eLIBRARY systems to prepare sections of the document in accordance with the established tasks. When finalizing the document, experts answered 28 questions: during anonymous voting an individual score was determined for each block from 1 – completely disagree, to 5 – completely agree. It was considered that a strong consensus was achieved with a mean score of M±m 2.5±2, and with a mean score below 2.5, consensus was not achieved. A strong consensus was reached on all issues.
- 15 April 2025
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 97 (3) , 279-288
Open AccessExpert consensus on approaches to risk stratification and choice of therapy in patients with inoperable and residual chronic thromboembolic pulmonary hypertension
On December 13, 2024, the final working group meeting was held, the purpose of which was to discuss the common position of experts on the problem of chronic thromboembolic pulmonary hypertension of various specialties: cardiologists, cardiac surgeons, pulmonologists, on issues of assessing the operability of patients, risk stratification and choice of therapy in patients with inoperable and residual forms of pathology. The discussion field included a wide range of issues that often arise in real clinical practice, but specific answers to them are not given in national and foreign guidelines. On November 8, 2024, at the preparatory stage, 16 experts under the leadership of Academician of the Russian Academy of Sciences I.E. Chazova (chairman) formulated questions for the preparation of a consensus document (without discussion), consistently discussing the feasibility of including each issue in the document and distributing tasks for the final session. Then, at the intermediate stage, experts searched and systematized scientific information on the formulated questions in the PubMed and eLIBRARY systems to prepare sections of the document in accordance with the established tasks. When finalizing the document, experts answered 28 questions: during anonymous voting an individual score was determined for each block from 1 – completely disagree, to 5 – completely agree. It was considered that a strong consensus was achieved with a mean score of M±m 2.5±2, and with a mean score below 2.5, consensus was not achieved. A strong consensus was reached on all issues.
- 14 April 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (1)
Pulmonary arterial hypertension in disorders of porto-caval hemodynamics. The role of ultrasound diagnostics
Portal hypertension is a complex syndrome that effects the systemic circulation. Some authors name pulmonary hypertension with portal hypertension such as portopulmonary hypertension. According to foreign registries, the prognosis of patients with portopulmonary hypertension is one of the most unfavorable. Ultrasound diagnostic methods are ones of keis to confirm portopulmonary hypertension, while echocardiography detects high pressure in the pulmonary artery, liver ultrasound with vascular doppler reveals changes in portocaval blood flow. Aim. To analyze the clinical, functional and hemodynamic status of patients with pulmonary arterial hypertension with portocaval hemodynamic disorders. To demonstrate the significance of abdominal ultrasonic diagnostics in determining the genesis of pulmonary hypertension. Material and methods. The study enrolls 14 patients with portocaval disorders. There were 5 patients with cirrhotic portal hypertension, 6 patients with Abernethy malformation and 3 patients with surgical portocaval shunts among them. All patients had a complex examination that included laboratory tests, echocardiography, abdominal ultrasound with Doppler ultrasonography and the right heart catheterization. Results. Among 14 patients, portocaval hemodynamic abnormalities were detected more often in women (73.3%). The mean age was 53.2±10.9 years. We knew about 5 patients (10%) with diagnosis of liver cirrhosis, three patients (5%) had got surgical portocaval shunts, 6 (10%) patients had Abernethy malformation. According to echocardiography, right atrial area was 25.3±2.3 cm2, pulmonary artery systolic pressure was 96±10.8 mm Hg. According to right heart catheterization data the median mean pulmonary arterial pressure was 59±10 mm Hg, SpO2 95.7±2.22%, cardiac output 4.6±0.9 L/min, the median pulmonary vascular resistance was 943.5±87.3 din sec/cm-5. The median 6-minute walking distance was 429.5±70.4 meters, which was corresponding to WHO functional class II, the median Borg dyspnea index was 4±1.7. Conclusions. All patients with pulmonary hypertension are shown to exclude portocaval shunts. The study of clinical features, functional and hemodynamic status of these patients will help to find the optimal treatment and tactical solutions.
- 14 April 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (1)
Pulmonary arterial hypertension in disorders of porto-caval hemodynamics. The role of ultrasound diagnostics
Portal hypertension is a complex syndrome that effects the systemic circulation. Some authors name pulmonary hypertension with portal hypertension such as portopulmonary hypertension. According to foreign registries, the prognosis of patients with portopulmonary hypertension is one of the most unfavorable. Ultrasound diagnostic methods are ones of keis to confirm portopulmonary hypertension, while echocardiography detects high pressure in the pulmonary artery, liver ultrasound with vascular doppler reveals changes in portocaval blood flow. Aim. To analyze the clinical, functional and hemodynamic status of patients with pulmonary arterial hypertension with portocaval hemodynamic disorders. To demonstrate the significance of abdominal ultrasonic diagnostics in determining the genesis of pulmonary hypertension. Material and methods. The study enrolls 14 patients with portocaval disorders. There were 5 patients with cirrhotic portal hypertension, 6 patients with Abernethy malformation and 3 patients with surgical portocaval shunts among them. All patients had a complex examination that included laboratory tests, echocardiography, abdominal ultrasound with Doppler ultrasonography and the right heart catheterization. Results. Among 14 patients, portocaval hemodynamic abnormalities were detected more often in women (73.3%). The mean age was 53.2±10.9 years. We knew about 5 patients (10%) with diagnosis of liver cirrhosis, three patients (5%) had got surgical portocaval shunts, 6 (10%) patients had Abernethy malformation. According to echocardiography, right atrial area was 25.3±2.3 cm2, pulmonary artery systolic pressure was 96±10.8 mm Hg. According to right heart catheterization data the median mean pulmonary arterial pressure was 59±10 mm Hg, SpO2 95.7±2.22%, cardiac output 4.6±0.9 L/min, the median pulmonary vascular resistance was 943.5±87.3 din sec/cm-5. The median 6-minute walking distance was 429.5±70.4 meters, which was corresponding to WHO functional class II, the median Borg dyspnea index was 4±1.7. Conclusions. All patients with pulmonary hypertension are shown to exclude portocaval shunts. The study of clinical features, functional and hemodynamic status of these patients will help to find the optimal treatment and tactical solutions.